Developer docs
API playgroundTry for free, no card

Search company profiles

EnvoyAI

Full company profile

uuid000qs7y

Namestring
EnvoyAI
Legal namestring
TeraRecon
Websiteurl
envoyai.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

EnvoyAI is a Cambridge, Massachusetts-based private company founded in 2016 that delivers AI-powered medical imaging software for clinical workflows in radiology, cardiology, and neurology. Its operating identity in the market is TeraRecon, a wholly-owned subsidiary of ConcertAI, which provides advanced visualization and AI decision support to hospitals, health systems, and academic medical centers. Named flagship customers include Emory University (cardiothoracic radiology) and Duke University (lung screening and chest radiograph analysis).

The technology stack centers on a SaaS-based advanced medical imaging platform composed of three flagship products: TeraRecon AV (next-generation SaaS visualization platform with AI-driven automations, registered as 'Intuition' in global markets), TeraRecon DETECT (AI Biomarker solution enabling enterprise-wide adoption of reimbursable AI findings), and TeraRecon Neuro (neurology imaging analysis). Supporting capabilities include proprietary Bone Suppression technology for chest radiographs and an Enterprise Imaging Decision Support layer that allows physicians to accept, reject, or adjust AI findings from the surgical suite through point of care. The platform is integrated into hospital IT environments through formalized AI Partners and PACS Partners channel ecosystems.

The business model is subscription-based enterprise SaaS sold via direct field sales to healthcare providers, with 'Request a Demo' and 'Free Trial' CTAs on the website indicating a consultative enterprise sales motion. Pricing is not publicly disclosed and is negotiated bespoke. The company targets enterprise healthcare buyers (academic medical centers, hospitals, health systems) and pursues a vertical segmentation approach across radiology, cardiology, and neurology departments, with reimbursement-eligible AI Biomarkers as a key monetization lever. Founder and CEO is Misha Herscu; the firm is listed with 1–10 employees, though TeraRecon's operating scale is embedded within parent ConcertAI.

Short descriptiontext

EnvoyAI (operating as TeraRecon) provides AI-powered SaaS medical imaging software for radiology, cardiology, and neurology workflows at hospitals and academic medical centers, with flagship products including TeraRecon AV, DETECT AI Biomarkers, and Neuro, distributed through direct enterprise sales and PACS/AI partner channels.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersDurham, United States
HQ citystring
Durham
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
AI medical imaging, advanced visualization, radiology AI software, medical imaging SaaS, AI biomarker imaging
Industry4 codes
PRIMARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLAHABAJ
Radiology AI, CAD & Advanced Visualization Software
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLACALAC
Vendor Neutral Archive (VNA) & Enterprise Imaging Repositories
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLACABAM
Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity)
Healthcare & Life Sciences/Digital Health & Health IT/Health Information Exchange (HIE) & Interoperability
NAICS code1 code
  • Software Publishers513210
SIC code1 code
  • Services-Computer Integrated Systems Design7373
Product category
AI Medical Imaging Software
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Subscription-based SaaS Platform
TypeSubscription Recurring
Description

Consolidates multiple 3D and AI solutions into one powerful, subscription-based platform. The company positions itself as simplifying and scaling imaging workflows through a consolidated platform approach, reducing costs by replacing multiple point solutions.

terarecon.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 4 records shown
1TeraRecon AV
Description

SaaS-based advanced medical imaging platform with AI-driven automations for diagnostic precision, efficiency, and care.

terarecon.com
+3 more records
Core offering1 text field

EnvoyAI sells a SaaS-based AI-driven advanced medical imaging platform that consolidates multiple 3D visualization and AI biomarker solutions into a single subscription product for healthcare providers. The platform serves radiology, cardiology, and neurology imaging workflows with proprietary capabilities including TeraRecon AV (advanced visualization), TeraRecon DETECT (AI biomarker adoption), TeraRecon Neuro (neurology imaging), and Bone Suppression technology, enabling diagnostic precision, workflow efficiency, and reimbursable AI biomarker adoption across the imaging enterprise.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • AI-driven efficiency gains at important steps of the patient care path; increased throughput while saving physician and technologist time; improvements in time-to-treatment and patient outcomes
Product and service5 records
1TeraRecon AV
CategoryAdvanced Visualization / AI Imaging Software
Description

Next-generation SaaS-based advanced medical imaging platform with AI-driven automations for diagnostic precision, efficiency, and care enhancement across radiology, cardiology, and neurology. Registered as Intuition in global markets outside the TeraRecon AV branding.

2TeraRecon DETECT
CategoryAI Decision Support / Biomarker Detection
Description

AI-powered workflow solution helping healthcare providers drive adoption of reimbursable AI Biomarkers across their entire imaging enterprise. Components awaiting regulatory clearance in some markets.

3TeraRecon Neuro
CategoryNeurology Imaging Software
Description

AI-powered neurology imaging analysis and visualization solution for neuro imaging workflows across healthcare enterprises.

4TeraRecon Intuition
CategoryAdvanced Visualization Software
Description

Advanced visualization solution registered as Intuition in global markets outside the TeraRecon AV branding, providing the same underlying advanced imaging capabilities under regional naming.

5Premier Success
CategoryPremium Support Services
Description

Premium customer support and success service for TeraRecon imaging customers, providing dedicated technical assistance, training, and ongoing optimization for enterprise deployments.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

ConcertAI is the parent company of TeraRecon. TeraRecon represents ConcertAI's imaging solutions division. The company operates under the ConcertAI umbrella with shared branding and website domains (concertai.com). TeraRecon AV is described as the next generation of ConcertAI's imaging solutions.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Viz.ai delivers AI-driven care coordination and image analysis, most prominently for stroke and neurovascular workflows. It overlaps with TeraRecon Neuro on AI neurology imaging and is a direct enterprise radiology-AI competitor.

TypeDirect peer
Description

Aidoc provides an AI-powered clinical decision support and workflow platform for radiology, with FDA-cleared algorithms deployed across hospital systems. It directly competes with TeraRecon DETECT/Neuro on AI-augmented radiology workflows and enterprise imaging decision support.

TypeBroad incumbent
Description

Siemens Healthineers provides AI-Rad Companion and a wide range of imaging equipment and enterprise imaging software. It competes with TeraRecon at the modality/enterprise level, bundling AI into its broader imaging ecosystem.

4GE HealthCare (Edison)
TypeBroad incumbent
Description

GE HealthCare operates the Edison AI platform across imaging devices and software. Following the Caption Health acquisition, it is increasingly a direct AI imaging competitor and a broad incumbent in TeraRecon's enterprise accounts.

TypeBroad incumbent
Description

Philips offers IntelliSpace AI and a broad portfolio of imaging hardware, PACS, and clinical informatics. As a major incumbent, it competes indirectly through bundled enterprise imaging contracts and AI capabilities across its installed base.

6Nanox (formerly Nano-X Imaging)
TypeBroad incumbent
Description

Nanox is building a multi-vendor imaging and AI platform, including through its Zebra Medical Vision acquisition. It overlaps with TeraRecon on AI imaging software distribution and enterprise imaging services.

7Caption Health (GE HealthCare)
TypeDirect peer
Description

Caption Health developed AI-guided ultrasound acquisition and interpretation, particularly for cardiology. It competes with TeraRecon on AI-augmented cardiac imaging workflows and was acquired by GE HealthCare in Feb 2023.

TypeDirect peer
Description

Arterys offers a cloud-native AI imaging platform with deep-learning quantification across radiology and cardiology. It mirrors TeraRecon's SaaS-based advanced visualization and AI-augmented imaging approach.

TypeDirect peer
Description

Blackford provides an AI platform and marketplace that curates and distributes third-party radiology AI algorithms to imaging providers. It directly parallels TeraRecon's AI Partners channel and DETECT biomarker marketplace approach (now owned by Bayer).

10Zebra Medical Vision
TypeDirect peer
Description

Zebra Medical Vision develops AI algorithms for radiology imaging interpretation across multiple modalities and clinical conditions. Now part of Nanox, it competes with TeraRecon on AI imaging analytics and enterprise deployment.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

EnvoyAI

AI Medical Imaging Softwareenvoyai.com

EnvoyAI (operating as TeraRecon) provides AI-powered SaaS medical imaging software for radiology, cardiology, and neurology workflows at hospitals and academic medical centers, with flagship products including TeraRecon AV, DETECT AI Biomarkers, and Neuro, distributed through direct enterprise sales and PACS/AI partner channels.

What EnvoyAI does

EnvoyAI is a Cambridge, Massachusetts-based private company founded in 2016 that delivers AI-powered medical imaging software for clinical workflows in radiology, cardiology, and neurology. Its operating identity in the market is TeraRecon, a wholly-owned subsidiary of ConcertAI, which provides advanced visualization and AI decision support to hospitals, health systems, and academic medical centers. Named flagship customers include Emory University (cardiothoracic radiology) and Duke University (lung screening and chest radiograph analysis).

The technology stack centers on a SaaS-based advanced medical imaging platform composed of three flagship products: TeraRecon AV (next-generation SaaS visualization platform with AI-driven automations, registered as 'Intuition' in global markets), TeraRecon DETECT (AI Biomarker solution enabling enterprise-wide adoption of reimbursable AI findings), and TeraRecon Neuro (neurology imaging analysis). Supporting capabilities include proprietary Bone Suppression technology for chest radiographs and an Enterprise Imaging Decision Support layer that allows physicians to accept, reject, or adjust AI findings from the surgical suite through point of care. The platform is integrated into hospital IT environments through formalized AI Partners and PACS Partners channel ecosystems.

The business model is subscription-based enterprise SaaS sold via direct field sales to healthcare providers, with 'Request a Demo' and 'Free Trial' CTAs on the website indicating a consultative enterprise sales motion. Pricing is not publicly disclosed and is negotiated bespoke. The company targets enterprise healthcare buyers (academic medical centers, hospitals, health systems) and pursues a vertical segmentation approach across radiology, cardiology, and neurology departments, with reimbursement-eligible AI Biomarkers as a key monetization lever. Founder and CEO is Misha Herscu; the firm is listed with 1–10 employees, though TeraRecon's operating scale is embedded within parent ConcertAI.

EnvoyAI firmographics

Firmographics
Name
EnvoyAI
Legal name
TeraRecon
Website
https://envoyai.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
1–10 employees
Short description
EnvoyAI (operating as TeraRecon) provides AI-powered SaaS medical imaging software for radiology, cardiology, and neurology workflows at hospitals and academic medical centers, with flagship products including TeraRecon AV, DETECT AI Biomarkers, and Neuro, distributed through direct enterprise sales and PACS/AI partner channels.
Ownership category
akta.pro rank

EnvoyAI industry classification

Industry
Product category
AI Medical Imaging Software
NAICS
Software Publishers (513210)
SIC
Services-Computer Integrated Systems Design (7373)
akta.pro industry
PRIMARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLAHABAJ
Radiology AI, CAD & Advanced Visualization Software
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLACALAC
Vendor Neutral Archive (VNA) & Enterprise Imaging Repositories
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLACABAM
Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity)
Healthcare & Life Sciences/Digital Health & Health IT/Health Information Exchange (HIE) & Interoperability

Keywords

  • AI medical imaging
  • Advanced visualization
  • Radiology AI software
  • Medical imaging SaaS
  • AI biomarker imaging

Where EnvoyAI is headquartered

Location

Headquarters

HQ city
Durham
HQ country
United States
HQ region
North America

Offices1 record

Markets served

EnvoyAI business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Subscription-based SaaS Platform: Consolidates multiple 3D and AI solutions into one powerful, subscription-based platform. The company positions itself as simplifying and scaling imaging workflows through a consolidated platform approach, reducing costs by replacing multiple point solutions.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

EnvoyAI product offering

Product offering

Core offering

EnvoyAI sells a SaaS-based AI-driven advanced medical imaging platform that consolidates multiple 3D visualization and AI biomarker solutions into a single subscription product for healthcare providers. The platform serves radiology, cardiology, and neurology imaging workflows with proprietary capabilities including TeraRecon AV (advanced visualization), TeraRecon DETECT (AI biomarker adoption), TeraRecon Neuro (neurology imaging), and Bone Suppression technology, enabling diagnostic precision, workflow efficiency, and reimbursable AI biomarker adoption across the imaging enterprise.

Differentiator

Problem solved

Functional benefit

Brands

  • TeraRecon AV: SaaS-based advanced medical imaging platform with AI-driven automations for diagnostic precision, efficiency, and care.
  • TeraRecon DETECT
  • TeraRecon Neuro
  • TeraRecon Intuition

Products and services

  • TeraRecon AV Next-generation SaaS-based advanced medical imaging platform with AI-driven automations for diagnostic precision, efficiency, and care enhancement across radiology, cardiology, and neurology. Registered as Intuition in global markets outside the TeraRecon AV branding.
  • TeraRecon DETECT AI-powered workflow solution helping healthcare providers drive adoption of reimbursable AI Biomarkers across their entire imaging enterprise. Components awaiting regulatory clearance in some markets.
  • TeraRecon Neuro AI-powered neurology imaging analysis and visualization solution for neuro imaging workflows across healthcare enterprises.
  • TeraRecon Intuition Advanced visualization solution registered as Intuition in global markets outside the TeraRecon AV branding, providing the same underlying advanced imaging capabilities under regional naming.
  • Premier Success Premium customer support and success service for TeraRecon imaging customers, providing dedicated technical assistance, training, and ongoing optimization for enterprise deployments.

Quantifiable outcome

  • AI-driven efficiency gains at important steps of the patient care path; increased throughput while saving physician and technologist time; improvements in time-to-treatment and patient outcomes

Companies that use EnvoyAI

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles1 record

EnvoyAI technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

EnvoyAI partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • ConcertAIcoreStrategic or Co-development PartnerConcertAI is the parent company of TeraRecon. TeraRecon represents ConcertAI's imaging solutions division. The company operates under the ConcertAI umbrella with shared branding and website domains (concertai.com). TeraRecon AV is described as the next generation of ConcertAI's imaging solutions.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

EnvoyAI competitors and assessment

Company assessment

Direct peers

  • Viz.ai: Viz.ai delivers AI-driven care coordination and image analysis, most prominently for stroke and neurovascular workflows. It overlaps with TeraRecon Neuro on AI neurology imaging and is a direct enterprise radiology-AI competitor.
  • Aidoc: Aidoc provides an AI-powered clinical decision support and workflow platform for radiology, with FDA-cleared algorithms deployed across hospital systems. It directly competes with TeraRecon DETECT/Neuro on AI-augmented radiology workflows and enterprise imaging decision support.
  • Caption Health (GE HealthCare): Caption Health developed AI-guided ultrasound acquisition and interpretation, particularly for cardiology. It competes with TeraRecon on AI-augmented cardiac imaging workflows and was acquired by GE HealthCare in Feb 2023.
  • Arterys: Arterys offers a cloud-native AI imaging platform with deep-learning quantification across radiology and cardiology. It mirrors TeraRecon's SaaS-based advanced visualization and AI-augmented imaging approach.
  • Blackford Analysis: Blackford provides an AI platform and marketplace that curates and distributes third-party radiology AI algorithms to imaging providers. It directly parallels TeraRecon's AI Partners channel and DETECT biomarker marketplace approach (now owned by Bayer).
  • Zebra Medical Vision: Zebra Medical Vision develops AI algorithms for radiology imaging interpretation across multiple modalities and clinical conditions. Now part of Nanox, it competes with TeraRecon on AI imaging analytics and enterprise deployment.

Broad incumbents

  • Siemens Healthineers (AI-Rad Companion): Siemens Healthineers provides AI-Rad Companion and a wide range of imaging equipment and enterprise imaging software. It competes with TeraRecon at the modality/enterprise level, bundling AI into its broader imaging ecosystem.
  • GE HealthCare (Edison): GE HealthCare operates the Edison AI platform across imaging devices and software. Following the Caption Health acquisition, it is increasingly a direct AI imaging competitor and a broad incumbent in TeraRecon's enterprise accounts.
  • Philips (IntelliSpace AI): Philips offers IntelliSpace AI and a broad portfolio of imaging hardware, PACS, and clinical informatics. As a major incumbent, it competes indirectly through bundled enterprise imaging contracts and AI capabilities across its installed base.
  • Nanox (formerly Nano-X Imaging): Nanox is building a multi-vendor imaging and AI platform, including through its Zebra Medical Vision acquisition. It overlaps with TeraRecon on AI imaging software distribution and enterprise imaging services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

EnvoyAI social profiles

Digital presence

EnvoyAI financial estimates

Financial estimate

Revenue estimate

Valuation estimate

EnvoyAI leadership team

Management profile

Number of profiles

Profiles1 record

EnvoyAI funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

EnvoyAI M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EnvoyAI

What does EnvoyAI do?

EnvoyAI sells a SaaS-based AI-driven advanced medical imaging platform that consolidates multiple 3D visualization and AI biomarker solutions into a single subscription product for healthcare providers. The platform serves radiology, cardiology, and neurology imaging workflows with proprietary capabilities including TeraRecon AV (advanced visualization), TeraRecon DETECT (AI biomarker adoption), TeraRecon Neuro (neurology imaging), and Bone Suppression technology, enabling diagnostic precision, workflow efficiency, and reimbursable AI biomarker adoption across the imaging enterprise.

Is EnvoyAI a public or private company?

EnvoyAI is a private company. It is classified as corporate owned and is currently operating.

When was EnvoyAI founded?

EnvoyAI was founded in 2016. It employs 1 to 10 people.

Where is EnvoyAI based?

EnvoyAI is headquartered in Durham, United States, in the North America region.

How does EnvoyAI make money?

One revenue line is on record: subscription-based SaaS Platform.

Who are EnvoyAI's main competitors?

Direct peers on record are Viz.ai, Aidoc, Caption Health (GE HealthCare), Arterys, Blackford Analysis and Zebra Medical Vision. Broad incumbents are Siemens Healthineers (AI-Rad Companion), GE HealthCare (Edison), Philips (IntelliSpace AI) and Nanox (formerly Nano-X Imaging).

Does EnvoyAI have an API?

No public API is recorded for EnvoyAI.

What industry is EnvoyAI in?

EnvoyAI's product category is AI Medical Imaging Software. Its primary akta.pro industry code is HLACANAG, SaMD – Imaging & Signal Analysis (AI/ML), with a secondary code of HLAHABAJ, Radiology AI, CAD & Advanced Visualization Software. Its NAICS code is 513210 and its SIC code is 7373.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireMaxQ AI Partners with EnvoyAI to Distribute Accipio Artificial Intelligence Solutions to U.S. and E.U. Acute CareMaxQ AI announced a distribution agreement with EnvoyAI, a subsidiary of TeraRecon, to distribute its Accipio intracranial hemorrhage AI platform to U.S. and E.U. acute care hospitals. The Accipio Ix solution has received both FDA clearance and CE Mark certification, enabling its sale through EnvoyAI and TeraRecon's PACS distribution channels and installed customer base. The partnership aims to accelerate adoption of AI-enabled clinical diagnostics in emergency rooms and for clinical research purposes.GlobeNewswireEnvoyAI Partners with Mach7 Technologies to expand AI to Enterprise Imaging, VNA, and PACSEnvoyAI entered a distribution deal with Mach7 Technologies to give Mach7 customers access to EnvoyAI's AI applications. The deal includes a direct integration between Mach7's VNA and EnvoyAI's cloud for serverless deployment. The partnership aims to expand AI tools for imaging enterprise customers.GlobeNewswireWake Radiology Launches EnvoyAI Platform in First-of-Kind ImplementationEnvoyAI completed its first customer installation at Wake Radiology in Raleigh, North Carolina, giving physicians access to over 53 AI engines for medical imaging. Wake Radiology has brought five imaging processing engines to pre-production status. The company expects many other US hospitals to follow.GlobeNewswireEnvoyAI, TeraRecon, and Insignia Partner to bring Artificial Intelligence to United Kingdom CustomersEnvoyAI announced an integration with Insignia Medical Systems' InSight PACS to deliver AI-enhanced imaging workflows to UK customers. The integration provides access to 53 products from 22 partners, 10 of which have US FDA clearance. The partnership aims to expand future workflow integrations with TeraRecon's visualization solutions.GlobeNewswireEnvoyAI, Ambra Health, and TeraRecon Deliver First End-to-End AI StrategyTeraRecon, EnvoyAI, and Ambra Health announced a collaboration to provide an AI-enhanced image exchange workflow at HIMSS18. The partnership gives Ambra network providers access to EnvoyAI's AI algorithms, with TeraRecon's iNtuition integrating EnvoyAI engines. Northstar, an AI results viewer, is debuting at the conference.GlobeNewswireRSNA17 AI Bone Age Challenge Champion, 16 Bit, Offers Award-Winning Algorithm on EnvoyAI Platform Free for Research UseEnvoyAI announced a partnership with 16 Bit, the winner of the RSNA Bone Age Algorithm Challenge. The algorithm achieved a mean absolute difference of 4.265 months on the test set, outperforming individual radiologists by 7.32 months. The algorithm is now available on EnvoyAI's developer portal for free research use.GlobeNewswireEnvoyAI launches with 35 algorithms contributed by 14 newly-contracted artificial intelligence development partnersEnvoyAI launched its EnvoyAI Exchange platform on Nov. 26, 2017, with 14 distribution deals contributing 35 algorithms. Three FDA-cleared algorithms are available for purchase immediately, with more expected over 6-12 months. The platform integrates AI into hospital workflows via a push-button interface.GlobeNewswireEnvoyAI launches with 35 algorithms contributed by 14 newly-contracted artificial intelligence development partnersEnvoyAI launched its EnvoyAI Exchange platform on Nov. 26, 2017, with 14 partner companies contributing 35 algorithms. Three FDA-cleared algorithms are available for purchase immediately, with more expected over 6-12 months. The platform integrates AI algorithms into hospital workflows.